AKERS BIOSCIENCES, INC. (NASDAQ:AKER) Files An 8-K Other Events
Item 8.01 Other Events.
On May 18, 2020, Akers Biosciences, Inc. issued a press release announcing the closing of its previously announced registered direct offering. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is hereby incorporated by reference herein.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
| 99.1 | Press release, dated May 18, 2020 |
Akers Biosciences, Inc. Exhibit
EX-99.1 2 ex99-1.htm Exhibit 99.1 Akers Biosciences Closes $4.8 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules Thorofare,…
To view the full exhibit click here
